What are Lumigan Eye Drops 0.03%?
They are eye drops that contain 0.03% bimatoprost, the active ingredient that is used to lower high intraocular pressure (IOP) in patients having glaucoma or ocular hypertension. It is done through the enhancement of the outflow of watery humor, which in turn leads to a decrease in the possibility of harming the optic nerve and losing sight.
Lumigan Eye Drops 0.03% Symptoms (Effects & Side Effects)
Effects (Benefits):
- Lowers eye pressure in open-angle glaucoma
- Reduces risk of optic nerve damage
- Enhances outflow of fluid from the eye
- May promote eyelash growth as a side effect
Common Side Effects:
- Eye redness or irritation
- Eyelash changes (thickening/darkening)
- Blurred vision temporarily
- Darkening of iris or eyelid skin
- Itchy or dry eyes
Lumigan Eye Drops 0.03% Causes
The treatment of Lumigan is not a disease but symptomatic. It is used to treat the conditions induced by:
- Primary open-angle glaucoma
- Ocular hypertension
- Post-surgical IOP elevation
- Genetic predisposition to elevated eye pressure
Lumigan Eye Drops 0.03% Uses (How It Benefits)
- The drug is particularly successful at decreasing the pressure inside the eye in patients with glaucoma.
- Drastically reduces the risk of loss of vision through damage to the optic nerves
- Outside of the approved indication, it is used to treat eyelash hypotrichosis (longer, thicker and darker eyelashes)
- Physician dispenses it for the patient’s regular treatment of glaucoma
Lumigan Eye Drops 0.03%: Mechanism of Action (MOA)
- Since Lumigan acts as a prostaglandin F2α analogue it stimulates the prostamide receptors in the eye
- It binds to the prostamide receptors in the eye.
- The medicine causes the uveal-scleral area of the aqueous humor to be more permeable
- It instantly regulates the intraocular pressure
- The drug’s beginning of action occurs after four hours and reaches its peak after eight to twelve hours.
Lumigan Eye Drops 0.03% Medication
- The medication is a bimatoprost of generic name
- Its strength is 0.03% in weight
- This is a clear eye only solution
- Various dropper bottles are used for packaging such as 3 ml and 5 ml
- It is to be stored at a temperature below 25°C and protect it from light
Lumigan Eye Drops 0.03% Medicines (Pills)
Lumigan’s sole form of medication is in the form of an eye drop and it does not have the pill or the oral form. Most importantly, it is only as effective as being applied to the eye the best way. Alternative Eye Drop: Bimat Eye Drops (With Brush), Super Lash (Bimatoprost Eye Drop)
Permanent Cure for Lumigan Eye Drops 0.03% Use
Lumigan is purchased repeatedly to make the glaucoma treatment permanent the medication is not featured as the treatment for the infection. Lumigan promises that the damage to the optic nerve or primary glaucoma is controlled and reversed it
FAQs
1.Can Lumigan 0.03% change eye color permanently?
Yes, prolonged use could result in an increase in iris brown pigmentation, which could be more predominant and thus be permanent, particularly in patients with mixed-color irises.
2.Is Lumigan safe to use with contact lenses?
Before the application, you should take off contact lenses and wait for at least 15 minutes before you put them back in, because of the benzalkonium chloride contained which can change the color or damage the lenses.
3.Can I use Lumigan to grow eyelashes?
Yes, the use of the drug for eyelash growth other than what it is marked for (Latisse) is something that has become quite common, provided it takes place under the doctor’s care who can eradicate any unwanted eye effects.
4.How long does Lumigan take to show results for the eye pressure?
The actual reduction in the load starts as soon as 4-8 hours are over, and it is usually at that time when you experience the highest effect. It is a must to use it regularly to monitor it.
5.What should I do if I miss a dose?
Should it occur that you skip the intended use of the drug, just resume your schedule and do not take a double dose as a cover for the skipped one.
Reviews
Clear filtersThere are no reviews yet.